A detailed history of Ethic Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ethic Inc. holds 439,819 shares of TAK stock, worth $5.69 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
439,819
Previous 365,331 20.39%
Holding current value
$5.69 Million
Previous $5.21 Million 17.19%
% of portfolio
0.16%
Previous 0.16%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.89 - $15.04 $1.03 Million - $1.12 Million
74,488 Added 20.39%
439,819 $6.11 Million
Q4 2023

Feb 14, 2024

SELL
$13.36 - $15.43 $1.29 Million - $1.49 Million
-96,516 Reduced 20.9%
365,331 $5.21 Million
Q3 2023

Nov 14, 2023

BUY
$15.03 - $16.32 $885,943 - $961,982
58,945 Added 14.63%
461,847 $7.14 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $733,705 - $806,274
47,123 Added 13.25%
402,902 $6.33 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $931,636 - $1 Million
60,971 Added 20.68%
355,779 $5.86 Million
Q4 2022

Feb 14, 2023

BUY
$12.42 - $15.62 $1.93 Million - $2.43 Million
155,562 Added 111.72%
294,808 $4.6 Million
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $251,097 - $562,027
-19,617 Reduced 12.35%
139,246 $1.81 Million
Q2 2022

Aug 10, 2022

SELL
$13.12 - $15.03 $1.15 Million - $1.32 Million
-87,765 Reduced 35.59%
158,863 $2.23 Million
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $1.45 Million - $1.64 Million
106,763 Added 76.33%
246,628 $3.53 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $663,557 - $826,297
50,384 Added 56.31%
139,865 $1.91 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $354,492 - $375,370
21,748 Added 32.11%
89,481 $1.47 Million
Q2 2021

Aug 10, 2021

BUY
$16.55 - $18.64 $172,748 - $194,564
10,438 Added 18.22%
67,733 $1.14 Million
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $356,758 - $424,864
21,350 Added 59.4%
57,295 $1.05 Million
Q4 2020

Feb 10, 2021

BUY
$15.39 - $18.97 $4,847 - $5,975
315 Added 0.88%
35,945 $654,000
Q3 2020

Oct 27, 2020

BUY
$17.1 - $19.19 $142,716 - $160,159
8,346 Added 30.59%
35,630 $636,000
Q2 2020

Aug 12, 2020

BUY
$14.59 - $19.5 $74,233 - $99,216
5,088 Added 22.92%
27,284 $489,000
Q1 2020

May 15, 2020

BUY
$13.02 - $20.31 $51,520 - $80,366
3,957 Added 21.7%
22,196 $337,000
Q4 2019

May 22, 2020

BUY
$16.88 - $20.83 $46,318 - $57,157
2,744 Added 17.71%
18,239 $360,000
Q4 2019

Feb 13, 2020

BUY
$16.88 - $20.83 $261,555 - $322,760
15,495 New
15,495 $306,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.